Á¬ÔƸۿµÀÖÒ©ÒµÓÐÏÞ¹«Ë¾
Lianyungang Kangle Pharmaceutical Co.,Ltd
È·ÈÏÎļþ
Validation Protocol and Report
ÌâÄ¿£º¸ßЧҺÏàÉ«Æ×ÒÇÐÔÄÜÈ·ÈÏ Îļþ±àºÅ£ºVL-007-08£¨2015£© Îļþ±£¹Ü²¿ÃÅ£ºÖʱ£²¿ ²¿ÃÅ/ÇøÓò£º»¯ÑéÊÒ È·ÈÏ¿ªÊ¼ÈÕÆÚ£º È·ÈÏÍê³ÉÈÕÆÚ£º È·Èϱ¨¸æÈÕÆÚ£º
VL-007-08£¨2015£© µÚ 1 Ò³ ¹² 20 Ò³
¸ßЧҺÏàÉ«Æ×ÒÇÐÔÄÜÈ·ÈÏ
Ŀ ¼
1. Ç©Ãû¼Ç¼ ............................................................................................................................ 2
1.1 1.2
È·ÈÏ·½°¸ÉóÅú±í ...................................................................................................................... 2 È·ÈÏС×é³ÉÔ±»áÇ©±í .............................................................................................................. 3
2. ¼ò½é .................................................................................................................................... 4
2.1 2.2 2.3 2.4 2.5
»ù±¾Çé¿ö .................................................................................................................................. 4 È·ÈÏÄ¿µÄ .................................................................................................................................. 4 È·ÈÏ·¶Î§ .................................................................................................................................. 4 Ïà¹ØÎļþ .................................................................................................................................. 4 Ö°ÔðÓë·Ö¹¤ .............................................................................................................................. 4
3. È·ÈÏ·½·¨ ............................................................................................................................ 5 4. È·Èϱê×¼ .......................................................................................................................... 11 5. È·ÈϽá¹ûÆÀ¶¨¼°½áÂÛ ............................................................................. ..........................15 6. È·Èϱ¨¸æ ...................................................................................................................................... 15
VL-007-08£¨2015£© µÚ 2 Ò³ ¹² 20 Ò³
1. Ç©Ãû¼Ç¼ 1.1 È·ÈÏ·½°¸ÉóÅú±í
¸ßЧҺÏàÉ«Æ×ÒÇÐÔÄÜÈ·ÈÏ
È·ÈÏ·½°¸ÉóÅú±í È·ÈÏÎļþ±àºÅ Îļþ±£¹Ü²¿ÃÅ ·½°¸Æð²Ý ÕÂÐãȺ ·½°¸ÉóºË ÅíÐãÁá ³ÂÌÎ ·½°¸Åú×¼ ÁõÈô¹È Ç©Ãû Ç©Ãû Ç©Ãû VL-007-08£¨2015£© ÖÊÁ¿±£Ö¤²¿ ÈÕÆÚ ÈÕÆÚ ÈÕÆÚ ÄúµÄÇ©Ãû±íÃ÷ÄúÒѾÉóÔÄ/Åú×¼ÁËÕâ·ÝÎļþ£¬Õâ·ÝÎļþ·ûºÏÈ·ÈÏ×ܼƻ®¡¢¹«Ë¾±ê×¼¡¢SOP»òÖÆ¶È£¬²¿ÃŵÄÒªÇóºÍÏÖÐÐGMP±ê×¼¡£±íÖÐËùÓÐÈËԱǩ×ÖÈ·ÈϺ󷽿Éʵʩ±¾·½°¸¡£
VL-007-08£¨2015£© µÚ 3 Ò³ ¹² 20 Ò³
1.2 È·ÈÏС×é³ÉÔ±»áÇ©±í
¸ßЧҺÏàÉ«Æ×ÒÇÐÔÄÜÈ·ÈÏ
С×é³ÉÔ±¼°»áÇ©±í С×éÖ°Îñ ×鳤 ²¿ÃÅ QC QC QC ³ÉÔ± QC QC QA QA Ö°Îñ»ò¸Úλ Ö÷ÈÎ ÒÇÆ÷×é×鳤 »¯ÑéÔ± »¯ÑéÔ± »¯ÑéÔ± QA¼ì²éÔ± Ö÷ÈÎ Ç©×Ö¼°ÈÕÆÚ ÄúµÄÇ©Ãû±íÃ÷ÄúÒѾÉóÔÄÁËÕâ·ÝÎļþ£¬²¢Ã÷°×ÄúÔÚ±¾È·ÈÏÖÐËù³Ðµ£µÄÖ°ÔðºÍ¹¤×÷¡£